The conjugate vaccine and invasive pneumococcal disease - Reply

被引:0
|
作者
Whitney, CG [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:715 / 716
页数:2
相关论文
共 50 条
  • [41] Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010
    Thoon, Koh Cheng
    Chong, Chia Yin
    Tee, Nancy Wen Sim
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : E209 - E215
  • [42] Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation
    Levy, Corinne
    Varon, Emmanuelle
    Ouldali, Naim
    Bechet, Stephane
    Bonacorsi, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 446 - 454
  • [43] Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
    Calbo, E.
    Diaz, A.
    Canadell, E.
    Fabrega, J.
    Uriz, S.
    Xercavins, M.
    Morera, M. A.
    Cuchi, E.
    Rodriguez-Carballeira, M.
    Garau, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) : 867 - 872
  • [44] Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
    Alexandrova Nikolova, Kristiana
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2024, 12 (02)
  • [45] Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
    Tomczyk, Sara
    Lynfield, Ruth
    Schaffner, William
    Reingold, Arthur
    Miller, Lisa
    Petit, Susan
    Holtzman, Corinne
    Zansky, Shelley M.
    Thomas, Ann
    Baumbach, Joan
    Harrison, Lee H.
    Farley, Monica M.
    Beall, Bernard
    Mcgee, Lesley
    Gierke, Ryan
    Pondo, Tracy
    Kim, Lindsay
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (09) : 1119 - 1125
  • [46] Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease
    Meng, Chun
    Lin, Haiying
    Huang, Jinzhong
    Wang, Hang
    Cai, Qianyin
    Fang, Liang
    Guo, Yanghao
    MICROBIAL PATHOGENESIS, 2009, 47 (03) : 151 - 156
  • [47] Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine
    Halasa, Natasha B.
    Shankar, Sadhna M.
    Talbot, Thomas R.
    Arbogast, Patrick G.
    Mitchel, Ed F.
    Wang, Winfred C.
    Schaffner, William
    Craig, Allen S.
    Griffin, Marie R.
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (11) : 1428 - 1433
  • [48] Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease
    Weatherholtz, Robert
    Millar, Eugene V.
    Moulton, Lawrence H.
    Reid, Raymond
    Rudolph, Karen
    Santosham, Mathuram
    O'Brien, Katherine L.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (09) : 1238 - 1246
  • [49] Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in older adults
    Hsiao, Amber
    Lewis, Ned
    Hansen, John
    Timbol, Julius
    Suaya, Jose A.
    Alexander-Parrish, Ronika
    Grant, Lindsay R.
    Gessner, Bradford D.
    Klein, Nicola P.
    VACCINE, 2025, 44
  • [50] Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era
    Olarte, Liset
    Lin, Philana Ling
    Barson, William J.
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Hoffman, Jill A.
    Bradley, John S.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)